Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Can a phone app help GLP-1 users eat better and move more?

NCT ID NCT07481305

Disease control Sponsor: University of Massachusetts, Worcester Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 24, 2026 · Last updated Jul 29, 2026 · Updated 3 times

Summary

This study will test whether a 4-month digital coaching program (Noom) helps adults who recently started GLP-1 medications improve their diet and physical activity. About 220 participants will use the app to track food and exercise, get coaching, and learn about managing challenges with GLP-1s. The goal is to see if this approach works in real-world settings and for different groups.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Digital lifestyle coaching program (Noom app with tailored modules for GLP-1 users)
What this could lead to
If successful, this could show that digital coaching helps people on GLP-1 medications adopt healthier habits, potentially improving long-term weight management and health outcomes.
What could go wrong
This is an early-stage implementation study, not a large-scale trial. Results may not apply to all GLP-1 users, and the program's effectiveness depends on participants sticking with it.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 220 people

The number the study aims to enrol. It can still change while the study runs.

Started

Jul 2026

Expected to finish

Sep 2029

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: 1. Began using a GLP-1 within the past 6 months 2. Currently using GLP-1 3. Plans to continue GLP-1 use 4. GLP-1 prescribed by their physician (e.g., not online or 3rd party vendor) 5. BMI ≥27 kg/m2 6. Age 18 years of age and older 7. Speaks and reads English or Spanish 8. Willing to enroll in a digital lifestyle intervention for 4-months 9. Willing to wear a Fitbit for 8 months Exclusion Criteria: 1. Was taking a GLP-1 within the 2 months prior to the current GLP-1 start date 2. Currently participating in a structured lifestyle change program (receiving structured guidance and counseling on physical activity, diet or weight loss) 3. Currently pregnant 4. Planning to become pregnant in the next year 5. Active diagnosis of an eating disorder

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for GLP-1 are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

Body Weight cardiovascular disorder diabetes mellitus Motor Activity

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

GLP-1

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • UMass Chan Medical School - Shaw Building

    RECRUITING

    Worcester, Massachusetts, 01605, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.